Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy
刊物主题:Oncology; Surgical Oncology; Cancer Research;
出版者:Springer Japan
ISSN:1437-7772
卷排序:22
文摘
BackgroundTo evaluate the association between the timing of best tumor shrinkage (bTS) and metastatic renal cell carcinoma (mRCC) patient survival after first-line tyrosine kinase inhibitor (TKI) therapy.